Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 5131 AL 5145

Angiostrongylus cantonensis central nervous system infection in captive callitrichids in Texas

Edwards EE, Borst MM, Lewis BC, Gomez G, Flanagan JP.

Vet Parasitol Reg Stud Reports. 2020 Jan;19:100363. doi: 10.1016/j.vprsr.2019.100363. Epub 2019 Dec 6.

Zebrafish as a Model System for the Study of Severe Ca(V)2.1 (α(1A)) Channelopathies

Tyagi S, Ribera AB, Bannister RA.

Front Mol Neurosci. 2020 Feb 7;12:329. doi: 10.3389/fnmol.2019.00329. eCollection 2019.

Synaptic Nuclear Envelope Protein 1 (SYNE 1) Ataxia with Amyotrophic Lateral Sclerosis-like Presentation: A Novel Synaptic Nuclear Envelope Protein 1 (SYNE 1) Gene Deletion Mutation from India

Nadaf SN, Chakor RT, Kothari KV, Mannan AU.

Ann Indian Acad Neurol. 2020 Jul-Aug;23(4):539-541. doi: 10.4103/aian.AIAN_448_18. Epub 2019 Apr 24.

"Chasing the Dragon": A Fatal Case Report of Toxic Leucoencéphalopathie Due to Inhaled Heroin

Ochoa-Orozco SA, Gutiérrez-Segura JC, Coral-Leiton AM, Trejos-Orozco EA, Gutiérrez-Sanjuán ÓI, Carvajal-Guevara JD.

Rev Colomb Psiquiatr (Engl Ed). 2020 Oct-Dec;49(4):289-292. doi: 10.1016/j.rcp.2019.06.003. Epub 2019 Aug 27.

Wernicke's encephalopathy: An uncommon complication from hyperemesis gravidarum

Shah R, Malhamé I, Fayek M, Merolli A, Mehta N.

Obstet Med. 2020 Dec;13(4):198-200. doi: 10.1177/1753495X18811515. Epub 2019 Jan 31.

The level of evidence of medical marijuana use for treating disabilities: a scoping review

Stetten N, Pomeranz J, Moorhouse M, Yurasek A, Blue AV.

Disabil Rehabil. 2020 May;42(9):1190-1201. doi: 10.1080/09638288.2018.1523952. Epub 2018 Nov 20.

Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015

Schneider M, Regente J, Greiner T, Lensky S, Bleich S, Toto S, Grohmann R, Stübner S, Heinze M.

Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):23-33. doi: 10.1007/s00406-018-0959-2. Epub 2018 Nov 30.

Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications

Yoshida K, Müller DJ.

Mol Neuropsychiatry. 2020 Apr;5(Suppl 1):1-26. doi: 10.1159/000492332. Epub 2018 Sep 26.

Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰

Chen W, Woo P, Murry T.

J Voice. 2020 Jul;34(4):598-603. doi: 10.1016/j.jvoice.2018.12.010. Epub 2018 Dec 28.

Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease

Vlagsma TT, Duits AA, Dijkstra HT, van Laar T, Spikman JM.

Neuropsychol Rehabil. 2020 Jan;30(1):67-84. doi: 10.1080/09602011.2018.1452761. Epub 2018 Mar 22.

Clinical and radiological findings of a rare case: reversible Parkinsonism in cerebral venous sinus thrombosis

Alis D, Alis C, Yazici ADE, Akdeniz YS, Apaydin H.

Acta Neurol Belg. 2020 Apr;120(2):491-493. doi: 10.1007/s13760-018-0930-z. Epub 2018 Apr 26.

An unusual initial presentation of Parkinson's disease: unilateral standing leg tremor

Al-Hashel JY, Kamel WA, Damier P, Abdulsalam AJ.

Acta Neurol Belg. 2020 Apr;120(2):415-416. doi: 10.1007/s13760-018-0920-1. Epub 2018 May 5.

The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?

Yan X, Uronen RL, Huttunen HJ.

Semin Cell Dev Biol. 2020 Mar;99:55-64. doi: 10.1016/j.semcdb.2018.05.005. Epub 2018 May 10.

A sticky situation: Aberrant protein-protein interactions in Parkinson's disease

Brown J, Horrocks MH.

Semin Cell Dev Biol. 2020 Mar;99:65-77. doi: 10.1016/j.semcdb.2018.05.006. Epub 2018 May 10.

Short-afferent inhibition and cognitive impairment in Parkinson's disease: A quantitative review and challenges

Martin-Rodriguez JF, Mir P.

Neurosci Lett. 2020 Feb 6;719:133679. doi: 10.1016/j.neulet.2018.06.048. Epub 2018 Jun 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias